ASX:ZLDPharmaceuticals
Is Zelira Therapeutics (ASX:ZLD) In A Good Position To Invest In Growth?
Even when a business is losing money, it's possible for shareholders to make money if they buy a good business at the...
ASX:CU6Pharmaceuticals
Individual investors invested in Clarity Pharmaceuticals Ltd (ASX:CU6) up 15% last week, insiders too were rewarded
A look at the shareholders of Clarity Pharmaceuticals Ltd ( ASX:CU6 ) can tell us which group is most powerful. And the...
ASX:AGHPharmaceuticals
We Think Althea Group Holdings (ASX:AGH) Needs To Drive Business Growth Carefully
There's no doubt that money can be made by owning shares of unprofitable businesses. For example, although Amazon.com...
ASX:MVPPharmaceuticals
Is Medical Developments International (ASX:MVP) In A Good Position To Deliver On Growth Plans?
Just because a business does not make any money, does not mean that the stock will go down. For example, although...
ASX:MXCPharmaceuticals
MGC Pharmaceuticals (ASX:MXC) Has Debt But No Earnings; Should You Worry?
Warren Buffett famously said, 'Volatility is far from synonymous with risk.' When we think about how risky a company...
ASX:RCEPharmaceuticals
Individual investors who hold 52% of Recce Pharmaceuticals Ltd (ASX:RCE) gained 39%, insiders profited as well
If you want to know who really controls Recce Pharmaceuticals Ltd ( ASX:RCE ), then you'll have to look at the makeup...
ASX:CAUPharmaceuticals
While shareholders of Cronos Australia (ASX:CAU) are in the black over 1 year, those who bought a week ago aren't so fortunate
It might be of some concern to shareholders to see the Cronos Australia Limited ( ASX:CAU ) share price down 19% in the...
ASX:WFLPharmaceuticals
Insiders who purchased Wellfully Limited (ASX:WFL) earlier this year lose an additional AU$80k as the stock sinks to AU$0.049
Insiders who bought AU$231k worth of Wellfully Limited's ( ASX:WFL ) stock at an average buy price of AU$0.075 over the...
ASX:MYXPharmaceuticals
Insiders who bought in the last 12 months lose an additional AU$32k as Mayne Pharma Group Limited (ASX:MYX) drops to AU$450m
The recent 12% drop in Mayne Pharma Group Limited's ( ASX:MYX ) stock could come as a blow to insiders who purchased...